logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Elite Group (01775.HK) issued 25.38 million shares according to the subscription agreement.

date
05/09/2025
Wisdom Finance and Economics APP news, Elite Group (01775.HK) announced on September 5, 2025, that it will issue 25.38 million shares according to the subscription agreement.
Latest
2 m ago
Saudi Arabia reportedly hopes that OPEC+ will increase production at a faster pace and is eager to regain the market share that has been eroded.
2 m ago
Bernstein raised the target stock price of CVS Health Corporation from $72 per share to $77 per share.
2 m ago
Bernstein raised the target stock price of CVS Health Corporation from $72 per share to $77.
2 m ago
Bernstein maintains its "market perform" rating on Westvis Health stocks.
2 m ago
Bernstein maintains a "market perform" rating on CVS Health stock.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.